ICD-10-CM Billable Code

C50.2

Malignant neoplasm of upper-inner quadrant of breast

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the upper-inner quadrant of the breast, classified under ICD-10 code C50.2, refers to a type of breast cancer that develops in the upper-inner area of the breast tissue. This specific location is one of the common sites for breast cancer and understanding its characteristics, causes, symptoms, and treatment options can help in early detection and management.

Causes & Symptoms

Clinical Causes: Genetic mutations and family history of breast cancer Hormonal factors, such as increased levels of estrogen and progesterone Exposure to radiation Lifestyle factors including alcohol consumption, smoking, and obesity Certain benign breast diseases that may increase cancer risk Age, with risk increasing as a person gets older Previous breast cancer or certain genetic syndromes

Key Symptoms: A lump or thickening in the upper-inner part of the breast Changes in the size, shape, or appearance of the breast Skin changes over the breast, such as dimpling or redness Nipple changes, including inversion or drainage Persistent pain or discomfort in the affected area Swelling of the nearby lymph nodes, especially in the armpit

Diagnostic & Treatment

Diagnosis Path: Mammography to detect abnormal masses and calcifications Ultrasound imaging to evaluate the nature of the lump Biopsy, including core needle biopsy or excisional biopsy, to obtain tissue for histopathological analysis Magnetic Resonance Imaging (MRI) may be used for detailed imaging Bone scans or CT scans if metastasis is suspected

Treatment Protocols: Surgical removal of the tumor, such as lumpectomy or mastectomy Radiation therapy to destroy remaining cancer cells in the breast Hormone therapy for hormone receptor-positive tumors, such as tamoxifen or aromatase inhibitors Chemotherapy to target cancer cells systemically Targeted therapy aimed at specific molecular markers of cancer Immunotherapy may be considered in certain cases Rehabilitation and supportive care to manage side effects and improve quality of life

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.2 a billable ICD-10 code?
Yes, C50.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.2?
Clinical documentation must specify the nature of Malignant neoplasm of upper-inner quadrant of breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference